[Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].

By Jorgen Vestbo. Ugeskrift for læger, 2004

1,259 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/6b9c809a8051c69d8e0e97461c51f73ee5ad26f7

Citations in the corpus

• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, unknown): “В ка! честве первой линии терапии рекомендуется комбина! ция ингаляционных ГКС/длительнодействующих β2!аго! нистов или длительнодействующих антихолинергических препаратов [195, 212, 214, 240, 244, 251, 388].”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, unknown): “An inhaled glucocorticosteroid combined with a long-acting b2-agonist is more effective than the individual components (123, 125, 126, 130, 131) (Evidence A).”
• Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease (2003, unknown): “In two 1-yr studies, the clinical effect of ICS on exacerbations requiring oral steroids was confirmed [5, 6]; the reduction in exacerbation frequency was less evident for patients taking ICS alone in the study by SZAFRANSKI et al.”